Sarah Gheuens - 21 Sep 2023 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Director
Signature
/s/ Lara Meisner, Attorney-in-Fact for Sarah Gheuens
Issuer symbol
VRDN
Transactions as of
21 Sep 2023
Net transactions value
$0
Form type
4
Filing time
25 Sep 2023, 16:35:04 UTC
Previous filing
06 Jul 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 21 Sep 2023 Common Stock 40,000 $15.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 36 equal monthly installments, subject to the Reporting Person's continued service to Issuer through each vesting date.